CTLA4 and neoplasm: In recent years, inhibitory checkpoints—including cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed cell death protein-1 (PD-1), and programmed cell death ligand 1 (PD-L1)—have been recognized to suppress anti-tumor immune responses in solid tumors [5].